EMBO Molecular Medicine (Sep 2022)

Systemic inflammation after stroke: implications for post‐stroke comorbidities

  • Alba Simats,
  • Arthur Liesz

DOI
https://doi.org/10.15252/emmm.202216269
Journal volume & issue
Vol. 14, no. 9
pp. n/a – n/a

Abstract

Read online

Abstract Immunological mechanisms have come into the focus of current translational stroke research, and the modulation of neuroinflammatory pathways has been identified as a promising therapeutic approach to protect the ischemic brain. However, stroke not only induces a local neuroinflammatory response but also has a profound impact on systemic immunity. In this review, we will summarize the consequences of ischemic stroke on systemic immunity at all stages of the disease, from onset to long‐term outcome, and discuss underlying mechanisms of systemic brain‐immune communication. Furthermore, since stroke commonly occurs in patients with multiple comorbidities, we will also overview the current understanding of the potential role of systemic immunity in common stroke‐related comorbidities, such as cardiac dysfunction, atherosclerosis, diabetes, and infections. Finally, we will highlight how targeting systemic immunity after stroke could improve long‐term outcomes and alleviate comorbidities of stroke patients.

Keywords